nerdexam
ASQ

CPGP · Question #123

The main goal of evaluating the level of action needed in response to adverse events is to: Response:

The correct answer is D. Protect patient safety and comply with regulatory requirements. Evaluating the level of action needed in response to adverse events is fundamentally a patient safety and regulatory compliance function - the primary obligation of healthcare organizations is to protect patients from harm and meet the standards set by bodies like the FDA…

Quality Systems

Question

The main goal of evaluating the level of action needed in response to adverse events is to:

Response:

Options

  • ADetermine the financial impact on the company.
  • BEnsure customer satisfaction and retention.
  • CMinimize legal liability for the company.
  • DProtect patient safety and comply with regulatory requirements.

How the community answered

(48 responses)
  • A
    15% (7)
  • B
    2% (1)
  • C
    8% (4)
  • D
    75% (36)

Explanation

Evaluating the level of action needed in response to adverse events is fundamentally a patient safety and regulatory compliance function - the primary obligation of healthcare organizations is to protect patients from harm and meet the standards set by bodies like the FDA, Joint Commission, or other regulatory authorities. Option A (financial impact) is a secondary business concern, not the driving purpose of adverse event evaluation. Option B (customer satisfaction) conflates patients with consumers and misframes the ethical and legal nature of healthcare obligations. Option C (minimizing legal liability) may be a byproduct of good adverse event management, but it is not the goal - prioritizing liability over patient safety would itself be an ethical and regulatory violation.

Memory tip: Think of adverse events as a "Safety First, Rules Always" framework - D stands for Duty to the patient and Due compliance with regulators. When in doubt, ask: "Who is most directly harmed?" - the patient - and "Who enforces the response?" - regulators. That always points back to D.

Topics

#Adverse Events#Patient Safety#Regulatory Compliance#GMP Principles

Community Discussion

No community discussion yet for this question.

Full CPGP Practice